MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs’ Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)
Summary
1996 Established INIT Co., Ltd. and assumed the position of Representative Director 2024 Appointed Chairman of the Board of MEDIROM Rehab Solutions, Inc.This press release and the information contained herein are not, and do not, constitute an offer to sell any securities or a solicitation of an offer to buy any securities in the United States or any other state or jurisdiction.Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. In some cases, forward-looking statements can be identified by terms such as may, will, should, design, target, aim, hope, expect, could, intend, plan, anticipate, estimate, believe, continue, predict, project, potential, goal, or other words that convey the uncertainty of future events or outcomes. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROMs control and which could, and likely will, affect actual results, levels of activity, performance or achievements. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.A subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), Mother Labs focuses on the health-tech sector. It uses innovative technology from a Silicon Valley tech company that allows for power generation based on temperature differences between body and surrounding air.